{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:03:31Z","timestamp":1784423011800,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tjpad.2025.100469","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T20:53:18Z","timestamp":1767732798000},"page":"100469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"13","author":[{"given":"James W.","family":"Kupiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-1738","authenticated-orcid":false,"given":"Anton P.","family":"Porsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-2935","authenticated-orcid":false,"given":"Raymond S.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-7727","authenticated-orcid":false,"given":"Suzanne","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Mallinckrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifulla","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Clarnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-6679","authenticated-orcid":false,"given":"Kee Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4303-3174","authenticated-orcid":false,"given":"Lindsay H.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tjpad.2025.100469_bib0001","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2666-7568(21)00140-9","article-title":"Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis","volume":"2","author":"Liang","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100469_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.25122\/jml-2019-0088","article-title":"Possibilities of dementia prevention - it is never too early to start","volume":"12","author":"Morovic","year":"2019","journal-title":"J Med Life"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100469_bib0003","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/hbm.25414","article-title":"Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: a longitudinal study","volume":"42","author":"Liu","year":"2021","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.tjpad.2025.100469_bib0004","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Corrleation between elevated levels of amyolid beta-peptide in the brain and cognitive decline","volume":"283","author":"N\u00e4slund","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100469_bib0006","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100469_bib0007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.tjpad.2025.100469_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons learned from the Alzheimer's amyloid b-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100469_bib0009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100469_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100469_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22085","article-title":"Targeting \u03b17 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development","author":"Burns","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.tjpad.2025.100469_bib0012","doi-asserted-by":"crossref","first-page":"25056","DOI":"10.1074\/jbc.M200066200","article-title":"\u03b2-amyloid peptide activates \u03b17 nicotinic acetylcholine receptors expressed in xenopus oocytes","volume":"227","author":"Dineley","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tjpad.2025.100469_bib0013","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"\u03b2-Amyloid1-42 binds to \u03b17 nicotinic acetylcholine receptor with high affinity:implication for Alzheimer\u2019s disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tjpad.2025.100469_bib0014","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","article-title":"Amyloid peptide A\u03b21-42 binds selectively and with picomolar affinity to \u03b17 nicotinic acetylcholine receptors","volume":"75","author":"Wang","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.tjpad.2025.100469_bib0015","doi-asserted-by":"crossref","first-page":"31547","DOI":"10.1074\/jbc.M212532200","article-title":"\u03b17 nicotinic acetylcholine receptors mediate \u03b2-amyloid peptide-induced tau protein phosphorylation","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tjpad.2025.100469_bib0016","article-title":"Structure and pathology of tau protein in Alzheimer disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-130545","article-title":"Microtubule depolymerization and tau phosphorylation","volume":"37","author":"Hern\u00e1ndez","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100469_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschemneuro.8b00632","article-title":"Phospho-tau impairs nuclear-cytoplasmic transport","volume":"10","author":"Tripathi","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JAD-2006-9S325","article-title":"Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective","volume":"9","author":"Iqbal","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100469_bib0020","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","article-title":"Reducing amyloid-related Alzheimer\u2019s disease pathogenesis by a small molecule targeting filamin A","volume":"32","author":"Wang","year":"2012","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.tjpad.2025.100469_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813927","article-title":"Simufilam reverses aberrant receptor interactions of filamin A in Alzheimer's disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjpad.2025.100469_bib0022","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2017.03.016","article-title":"PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2025.100469_bib0023","article-title":"Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer\u2019s disease patient lymphocytes","author":"Wang","year":"2023","journal-title":"Front Aging"},{"key":"10.1016\/j.tjpad.2025.100469_bib0024","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14283\/jpad.2020.6","article-title":"PTI-125 reduces biomarkers of Alzheimer\u2019s disease in patients","volume":"7","author":"Wang","year":"2020","journal-title":"J Prev Alzheimer's Dis"},{"issue":"Suppl 2","key":"10.1016\/j.tjpad.2025.100469_bib0025","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease assessment scale that broaden its scope. The Alzheimer's disease cooperative study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 2","key":"10.1016\/j.tjpad.2025.100469_bib0026","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's disease cooperative study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100469_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100469_bib0029","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100469_bib0030","first-page":"746","article-title":"Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database","volume":"67","author":"O'Bryant","year":"2010","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100469_bib0031","first-page":"227","article-title":"A combined measure of cognition and function for clinical trials: the integrated Alzheimer's Disease rating scale (iADRS)","volume":"2","author":"Wessels","year":"2015","journal-title":"J Prev Alzheimers Dis"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100469_bib0032","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100469_bib0033","series-title":"The Memory And Behavior Problems Checklist And The Burden Interview","author":"Zarit","year":"1990"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100469_bib0034","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100469_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0036","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.2005.072306","article-title":"Education and rates of cognitive decline in incident Alzheimer's disease","volume":"77","author":"Scarmeas","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100469_bib0037","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jalz.2016.01.002","article-title":"Longitudinal decline in mild-to-moderate Alzheimer's disease: analyses of placebo data from clinical trials","volume":"12","author":"Thomas","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"13","key":"10.1016\/j.tjpad.2025.100469_bib0038","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100469_bib0039","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100469_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100469_bib0041","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100469_bib0042","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100469_bib0043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jalz.2009.05.665","article-title":"Disease progression meta-analysis model in Alzheimer\u2019s disease","volume":"6","author":"Ito","year":"2010","journal-title":"Alzheimer's Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100469_bib0044","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100469_bib0045","article-title":"Inventors; Pain Therapeutics, Inc., assignee","author":"Wang","year":"2016","journal-title":"Method Inhib Growth Cancer Cells"},{"key":"10.1016\/j.tjpad.2025.100469_bib0046","series-title":"Paper presented at: European Congress of Endocrinology","article-title":"A novel filamin A-binding molecule may significantly enhance somatostatin receptor type 2 antitumoral actions in growth hormone-secreting PitNET cells","author":"Marra","year":"2023"},{"issue":"531","key":"10.1016\/j.tjpad.2025.100469_bib0047","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay0289","article-title":"Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725004108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725004108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:11:25Z","timestamp":1773947485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725004108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2274580725004108"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100469","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100469"}}